DEEDRA MEYERS: Open Payments
NPI 1235466673 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$685 in 22 payments from 11 companies in 2025. Trend: 2023 $972 · 2024 $1,973 · 2025 $685
Food & beverage: $531Education: $155
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $211 |
| LEO Pharma Inc. | 2 | $119 |
| GENZYME CORPORATION | 1 | $78 |
| Incyte Corporation | 3 | $71 |
| Organon LLC | 2 | $57 |
| Novartis Pharmaceuticals Corporation | 3 | $56 |
| UCB, Inc. | 1 | $24 |
| Arcutis Biotherapeutics, Inc. | 1 | $21 |
| Galderma Laboratories, L.P. | 1 | $18 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $17 |
Products named: TREMFYA, ANZUPGO, DUPIXENT, OPZELURA, VTAMA, Rhapsido, Bimzelx, Zoryve.
Industry payments across CO — which companies pay providers there.
